You have read all your free articles, to continue reading subscribe to read the rest of this content.
Mark Goldberger MD MPH infectious disease expert has joined the NDA Advisory Board. Mark brings with him a wealth of experience in and in-depth knowledge of infectious diseases and antimicrobial products as well as extensive FDA expertise, according to the press release. He has insight in these fAlready a subscriber…
This summer, the Board of Directors of the company appointed Deborah Dunsire as new president and CEO of Lundbeck. "It is a great pleasure to announce that Deborah Dunsire will join Lundbeck as President and CEO," says Lars Rasmussen, Chairman of Lundbeck's Board of Directors. “She brings a weaAlready a…
AlzeCure Pharma has announced the appointment of Märta Segerdahl, MD, PhD, Associate professor, as Chief Medical Officer (CMO). Segerdahl will be a member of AlzeCure’s executive management team and succeeds An van Es-Johansson, MD, currently CMO and Head of Development, and previously member Already a subscriber Login You have read…
Tony Hoos to replace Anders Ullman as Head of R&D and Medical Affairs and Chief Medical Officer from 1 April 2023. Anton (Tony) Hoos, M.D., Ph.D., MBA will become Head of R&D and Medical Affairs and Chief Medical Officer and replace Anders Ullman, M.D., Ph.D. who will retire. Tony Hoos…
